Bappaditya Dey

Title: Bappaditya Dey: Innovator in Cancer Treatment

Introduction

Bappaditya Dey is a prominent inventor based in Baltimore, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. With a total of 3 patents, Dey is recognized for his groundbreaking work in utilizing bacteria for therapeutic applications.

Latest Patents

One of Dey's latest patents focuses on methods of treating cancer using bacteria that express c-di-AMP. This invention includes the discovery of a strain that comprises an expression vector encoding a di-adenylate cyclase enzyme. The preferred strain for this application is BCG, and the expression vector is a mycobacterial expression vector that includes an hsp60 promoter and a DNA sequence of diadenylate cyclase (disA), or a functional part thereof. These strains are utilized in therapeutic applications, including treatments for tuberculosis and cancer.

Career Highlights

Bappaditya Dey is affiliated with The Johns Hopkins University, where he conducts his research and develops his innovative methods. His work has garnered attention in the scientific community for its potential impact on cancer treatment.

Collaborations

Dey collaborates with notable colleagues, including William R. Bishai and Ruchi Jain Dey, who contribute to his research endeavors and help advance the field of cancer therapy.

Conclusion

Bappaditya Dey's contributions to cancer treatment through innovative methods and patents highlight his role as a leading inventor in the field. His work continues to pave the way for new therapeutic approaches that could significantly benefit patients.